Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

(2018) X. Montalban et al.   EUROPEAN JOURNAL OF NEUROLOGY

Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis

(2018) Stuart Cook et al.   Multiple Sclerosis and Related Disorders

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

(2014) Chiara Pecori et al.   BMC Neurology

Multiple Sclerosis: Current Knowledge and Future Outlook

(2014) Christian P. Kamm et al.   EUROPEAN NEUROLOGY

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

(2014) Thomas P Leist et al.   LANCET NEUROLOGY

Birth outcomes of pregnancies fathered by men with multiple sclerosis

(2014) E Lu et al.   Multiple Sclerosis Journal

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

(2014) Neda Ebrahimi et al.   Multiple Sclerosis Journal

What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature

(2011) A Finkelsztejn et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Birth outcomes in women who have taken leflunomide during pregnancy

(2010) Christina D. Chambers et al.   ARTHRITIS AND RHEUMATISM

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

(2010) Gavin Giovannoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of oral cladribine for the treatment of multiple sclerosis

(2009) Hans-Peter Hartung et al.   JOURNAL OF NEUROLOGY

Parenthood and immunomodulation in patients with multiple sclerosis

(2009) Kerstin Hellwig et al.   JOURNAL OF NEUROLOGY